Celgene Lands Big CAR-T Deal With Juno – At A Big Price
This article was originally published in The Pink Sheet Daily
Executive Summary
Celgene is staking a leadership claim in immuno-oncology through a broad, 10-year collaboration with one of the leading CAR-T developers, Juno Therapeutics.